Madhavi Venigalla, MD
Medical Oncology · Sarasota, FLNPI 1558393850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $282 of the $394 with a category attached, or 71.6%. 8 manufacturers reported payments, led by Johnson & Johnson at 29.6% of the total. 2024 is the largest year on record at $204, 2.0 times the $100 reported in 2020. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 10 payments — averaging $39.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$117
- Viiv Healthcare Company$107
- AbbVie$67
- Takeda Pharmaceuticals U.S.A., Inc.$30
- Jazz Pharmaceuticals Inc.$26
- Bayer$20
- plus $28 from 2 others
Across 10 payments — averaging $10,824 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$100K
- AbbVie$7K
- Pharmacyclics LLC, An Abbvie Company$1K
What the payments were for
- Food & beverage$28272%
- Education$11228%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $117 |
| Viiv Healthcare Company | 1 | $107 |
| AbbVie | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Bayer | 1 | $20 |
| Bristol Myers Squibb | 1 | $16 |
| Gilead | 1 | $12 |
How this compares
$394 in reported general payments places this provider in the 10th percentile of 507 medical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Sarasota
- Manish PatelSarasota$123K
- Judy WangSarasota$64K
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.